Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
18.56
+1.57 (9.24%)
At close: Jun 26, 2026, 4:00 PM EDT
18.06
-0.50 (-2.69%)
After-hours: Jun 26, 2026, 5:26 PM EDT
Crescent Biopharma Employees
Crescent Biopharma had 55 employees as of March 31, 2026. The number of employees increased by 11 or 25.00% since the number was last reported on December 31, 2025.
Employees
55
Change
11
Growth
25.00%
Revenue / Employee
$216,055
Profits / Employee
-$2,946,855
Market Cap
616.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 55 | 11 | 25.00% |
| Dec 31, 2025 | 44 | 38 | 633.33% |
| Dec 31, 2024 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| REGENXBIO | 371 |
| 4D Molecular Therapeutics | 196 |
| Prime Medicine | 146 |
| Tectonic Therapeutic | 60 |
| Altimmune | 57 |
| Achieve Life Sciences | 28 |
CBIO News
- 1 day ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 19 days ago - Crescent Biopharma Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Crescent Biopharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Crescent Biopharma to Present at June Investor Conferences - GlobeNewsWire
- 25 days ago - Crescent Biopharma Transcript: AGM 2026 - Transcripts
- 26 days ago - Crescent Biopharma downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 4 weeks ago - Crescent Biopharma Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 5 weeks ago - Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting - GlobeNewsWire